GenomeScan

GenomeScan is a privately-owned biotechnology company based in Leiden, The Netherlands, founded in 2002. It specializes in customizable Next Generation Sequencing solutions for the pharmaceutical, healthcare, and academic research sectors. The company's mission is to partner with hospitals, academic institutions, and global pharmaceutical and biotechnology companies to accelerate disease diagnostics and prediction, and improve patient outcomes for genetic disorders.

GenomeScan's unique offering lies in its tailored solutions developed in collaboration with clinical experts from the Erasmus Medical Center and Leiden University Medical Center. Its services portfolio includes whole exome sequencing, panel sequencing, transcriptomics, and epigenetics, with a focus on patient stratification strategies based on NGS genetic profiling for pharmaceutical companies.

Operating an accredited DNA testing facility, GenomeScan's in-house laboratory is equipped to provide genetic tests and deliver results within 48 hours. The company's industry-scale sequencers, robotics, and IT infrastructure are designed to accommodate both research and diagnostics projects, supported by a dedicated bioinformatics team.